Spinal Resources — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Spinal Resources Inc. is a commercial-stage medical device company specializing in next-generation spinal fusion hardware. Its flagship technology is the Bezier Parametric Curve Rod, an FDA-cleared implant designed to provide a graduated stiffness transition along the spinal construct, aiming to reduce complications like proximal junctional kyphosis (PJK). The company's product portfolio, which also includes the versatile Swedge™ screw system, targets cost-effective, patient-specific care in deformity and degenerative spinal surgery. SRI appears to be in an early commercial growth phase, leveraging recent regulatory clearances and patent protections to capture market share.

OrthopedicsSpinal Disorders

Technology Platform

Bezier Parametric Curve Transition Rod platform for graduated spinal stiffness and Swedge™ Pedicle Screw System for versatile rod-screw interface.

Opportunities

The recent FDA clearance for compatibility with any pedicle screw system dramatically expands the addressable market by allowing integration into surgeons' existing workflows.

The growing focus on value-based care in healthcare creates an opportunity for technologies that demonstrably reduce costly revision surgeries and improve OR efficiency.

Risk Factors

Commercial execution risk is high, as the company must build a sales footprint and drive adoption in a market dominated by large, entrenched competitors.

Clinical validation risk remains until long-term patient outcome data is generated to prove the hypothesized reduction in proximal junctional complications.

Competitive Landscape

SRI competes in the multi-billion dollar spinal implants market against giants like Medtronic, Stryker, and Johnson & Johnson, as well as larger spine specialists like NuVasive and Globus Medical. Its differentiation is a focused biomechanical solution (Bezier rod) for a specific complication profile, rather than a full portfolio of spinal implants.

More companies in Regenerative Medicine →More companies in United States →